Publikationen in Zusammenarbeit mit Forschern von Pontificia Universidad Católica de Chile (9)

2024

  1. Letter to the Editor: Serum Identification of At-Risk MASH: The Metabolomics-Advanced Steatohepatitis Fibrosis Score (MASEF)

    Hepatology

  2. Serum identification of at-risk MASH: The metabolomics-advanced steatohepatitis fibrosis score (MASEF)

    Hepatology, Vol. 79, Núm. 1, pp. 135-148

2023

  1. Validation and optimization of AFP-based biomarker panels for early HCC detection in Latin America and Europe

    Hepatology Communications, Vol. 7, Núm. 10

2021

  1. Next-generation biomarkers for cholangiocarcinoma

    Cancers, Vol. 13, Núm. 13

  2. The altered serum lipidome and its diagnostic potential for Non-Alcoholic Fatty Liver (NAFL)-associated hepatocellular carcinoma: Diagnosis of NAFLD-HCC utilising serum lipidomics

    EBioMedicine, Vol. 73

2020

  1. Extracellular Vesicles in NAFLD/ALD: From Pathobiology to Therapy

    Cells, Vol. 9, Núm. 4

  2. Extracellular vesicles in non-alcoholic fatty liver disease: Key players in disease pathogenesis and promising biomarker tools

    NAFLD and NASH: Biomarkers in Detection, Diagnosis and Monitoring (Springer International Publishing), pp. 157-180

  3. Integrative proposal for the use of biomarkers in clinical practice management of NAFLD/NASH

    NAFLD and NASH: Biomarkers in Detection, Diagnosis and Monitoring (Springer International Publishing), pp. 225-236

2017

  1. Pharmacologic antagonism of dopamine receptor D3 attenuates neurodegeneration and motor impairment in a mouse model of Parkinson's disease

    Neuropharmacology, Vol. 113, pp. 110-123